Pharmacokinetics: Model structure and transport systems

Transport Processes in Pharmaceutical Systems

Volumn , Issue , 1999, Pages 55-86

  Gallo, James M ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85056046735     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9780203909478     Document Type: Chapter

References (61)

1. JG Wagner. History of pharmacokinetics. Pharmacol Ther 12:537-562, 1981.
2. K Godfrey. Compartmental Models and Their Application. London: Academic Press, 1983.
3. EA Nuesch. Noncompartmental approaches in pharmacokinetics using moments. Drug Metab Rev 15:103-131, 1984.
4. JJ DiStefano III. Noncompartmental vs. compartmental analysis: Some bases for choice. Am J Physiol 243:R1-R6, 1982.
5. P Veng-Pedersen. Linear and nonlinear systems approach in pharmacokinetics: How much do they have to offer? I. General considerations. J Pharmacokin Biopharm 16:413-472, 1988.
6. T Teorell. Kinetics of distribution of substances administered to the body. I. The extravascular modes of administration. Arch Int Pharmacodyn Ther 57:226-255, 1937.
7. T Teorell. Kinetics of distribution of substances administered to the body. II. The intravascular modes of administration. Arch Int Pharmacodyn Ther 57:226-240, 1937.
8. R Bellman, JA Jacquez, R Kalaba. Some mathematical aspects of chemotherapy. I. One organ models. Bull Math Biophys 22:181-198, 1960.
9. KB Bischoff, RG Brown. Drug distribution in mammals. Chem Eng Prog Symp 62: 33-45, 1966.
10. RL Dedrick, KB Bischoff. Pharmacokinetics in applications of the artificial kidney. Chem Eng Prog Symp Ser 64:32-44, 1968.
11. JM Gallo, CT Hung, PK Gupta, DG Perrier. Physiological pharmacokinetic model of adriamycin delivered via magnetic albumin microspheres in the rat. J Pharmacokin Biopharm 17:305-326, 1989.
12. JC Dearden. Molecular structure and drug transport. In: CA Ramsden, ed. Comprehensive Medicinal Chemistry, Vol. 4, Quantitative Drug Design. New York: Pergamon Press, 1990, pp 375-411.
13. GE Blakey, IA Nestorov, PA Arundel, LJ Aarons, M Rowland. Quantitative structure-pharmacokinetics relationships. I. Development of a whole body physiologically based model to characterize changes in pharmacokinetics across a homologous series of barbiturates in the rat. J Pharmacokin Biopharm 25:277-312, 1997.
14. KH Watanabe, FY Bois. Interspecies extrapolations of physiological pharmacokinetic parameter distributions. Risk Anal 16:741-754, 1996.
15. H Boxenbaum, R Ronfeld. Interspecies pharmacokinetic scaling and the Dedrick plots. Am J Physiol 245:R768-R774, 1983.
16. Y Igari, Y Sugiyama, Y Sawada, T Iga, M Hanano. Prediction of diazepam disposition in the rat and man by a physiologically based pharmacokinetic model. J Pharmacokin Biopharm 11:577-593, 1983.
17. BA Patel, FD Boudinot, RF Schinazi, JM Gallo, CK Chu. Comparative pharmacokinetics and interspecies scaling of 3-azido-3-deoxythymidine (AZT) in several mammalian species. J Pharmacobiol Dynam 13:206-211, 1990.
18. RK Jain, LE Gerlowski. Extravascular transport in normal and tumor tissues. CRC Crit Rev Oncol Hematol 5:115-170, 1985.
19. RK Jain, J Wei. Dynamics of drug transport in solid tumors: Distributed parameter models. J Bioeng 1:313-330, 1977.
20. LZ Benet. General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics. J Pharm Sci 6:536-541, 1972.
21. CR Wylie. Advanced Engineering Mathematics. 4th ed. New York: McGraw-Hill, 1975, pp 289-294.
22. JM Weissbrod. A comprehensive approach to whole body pharmacokinetics in mammalian systems: Applications to methotrexate, streptozotocin and zinc. DSc Eng dissertation, Columbia University, New York, 1979, pp 110-112.
23. D Shen, M Gibaldi. Critical evaluation of use of effective protein fractions in developing pharmacokinetic models for drug distribution. J Pharm Sci 63:1698-1702, 1974.
24. KB Bischoff. Some fundamental considerations of the applications of pharmacokinetics to cancer chemotherapy. Cancer Chemother Rep 59:777-793, 1975.
25. WR Gillespie, LL Cheung, HJ Kim, JV Bruckner, JM Gallo. Application of system analysis to toxicology: Characterization of carbon tetrachloride oral absorption kinetics. In: TR Gererity, CJ Henry, eds. Principles of Route-to-Route Extrapolation for Risk Assessment. Amsterdam, Netherlands: Elsevier Science, 1990, pp 285-295.
26. JM Gallo, LL Cheung, HJ Kim, JV Bruckner, WR Gillespie. A physiological and system analysis hybrid pharmacokinetic model to characterize carbon tetrachloride blood concentrations following administration in different oral vehicles. J Pharmacokin Biopharm 21:551-574, 1993.
27. K Zierler. A critique of compartmental models. Ann Rev Biophys Bioeng 10:531-562, 1981.
28. G Cobelli, JJ DiStefano III. Parameter and structural identifiability concepts and ambiguities: A critical review and analysis. Am J Physiol 239:R7-R24, 1980.
29. DM Gibon, ME Taylor, WA Colburn. Curve fitting and unique parameter identification. J Pharm Sci 76:658-659, 1987.
30. M Gibaldi, DG Perrier. Pharmacokinetics. 2nd ed. New York: Marcel Dekker, 1982, pp 433-444.
31. KR Godfrey, RP Jones, RF Brown. Identifiable pharmacokinetic models: The role of extra inputs and measurements. J Pharmacokin Biopharm 8:633-648, 1980.
32. CM Metzler, GL Elfring, AJ McEwen. A User’s Manual for NONLIN and Associated Programs. Kalamazoo, MI: The Upjohn Co., 1974.
33. DZ D’Argenio, A Schumitzky. ADAPT II User’s Guide. Biomedical Simulations Resource. Los Angeles, CA: University of Southern California, 1990.
34. M Berman, WF Beltz, PC Greif, R Chabay, RC Boston. CONSAM User’s Guide. Bethesda, MD: US Department of Health and Human Services, 1983.
35. HG Boxenbaum, S Riegelman, RM Elashoff. Statistical estimation in pharmacokinetics. J Pharmacokin Biopharm 2:123-148, 1974.
36. K Yamaoka, T Nakagawa, T Uno. Application of Akaike’s information criteria (AIC) in the evaluation of linear pharmacokinetic model. J Pharmacokin Biopharm 6:165-175, 1978.
37. PL Altman, DS Dittmer, eds. Dittmer Biology Data Book, Vols 1 and 3. 2nd ed. Bethesda, MD: Federation of American Societies for Experimental Biology, 1972 and 1974.
38. LE Gerlowski, RK Jain. Physiologically based pharmacokinetic modeling: Principles and applications. J Pharm Sci 72:1103-1127, 1983.
39. WS Spector, ed. Handbook of Biological Data. Philadelphia, PA: WB Saunders, 1956.
40. RP Brown, MDDelp, SL Lindstedt, LR Rhomberg, RP Beliles. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol Ind Health 13:407-484, 1997.
41. L Jansky, JS Hart. Cardiac output and organ blood flow in warm and cold-acclimated rats exposed to cold. Can J Physiol Pharmacol 46:653-659, 1968.
42. NA Lassen, W Perl. Tracer Kinetic Methods in Medical Physiology. New York: Raven Press, 1979.
43. MD Delp, RO Manning, JV Bruckner, RB Armstrong. Distribution of cardiac output during diurnal changes of activity in rats. Am J Physiol 261:H1-H7, 1991.
44. PL Altman, DS Dittmer, eds. Respiration and Circulation. Bethesda, MD: Federation of American Societies for Experimental Biology, 1971.
45. CN Chen, JD Andrade. Pharmacokinetic model for simultaneous determination of drug levels in organs and tissues. J Pharm Sci 65:717-724, 1976.
46. AD Arms, CC Travis. Reference Physiological Parameters in Pharmacokinetic Modeling. Washington, DC: US Environmental Protection Agency, February 1988.
47. JH Lin, Y Sugiyama, S Awazu, M Hanano. In vitro and in vivo evaluation of the tissue-to-blood partition coefficients for physiological pharmacokinetic models. J Pharmacokin Biopharm 10:637-647, 1982.
48. HSG Chen, JF Gross. Estimation of tissue-to-plasma partition coefficients used in physiological pharmacokinetic models. J Pharmacokin Biopharm 7:117-125, 1979.
49. JM Gallo, FC Lam, DG Perrier. Area method for the estimation of partition coefficients used in physiological pharmacokinetic models. J Pharmacokin Biopharm 15: 271-280, 1987.
50. WD Stein. Transport and Diffusion Across Cell Membranes. Orlando, FL: Academic Press, 1986, pp 52-68.
51. MV Shah, KL Audus, RT Borchardt. The application of bovine brain microvessel endothelial-cell monolayers grown onto polycarbonate membranes in vitro to estimate the potential permeability of solutes through the blood-brain barrier. Pharm Res 6:624-627, 1989.
52. JM Gallo, FC Lam, DG Perrier. Moment method for the estimation of mass transfer coefficients for physiological pharmacokinetic models. Biopharm Drug Dispos 12: 127-137, 1991.
53. R Brown, H Seifried. Extrapolation of in vivo metabolic rate constants from in vitro pharmacokinetic data.Washington, DC: US Environmental Protection Agency, 1988.
54. CF Chignell. Protein binding. In: ER Garrett, JL Hirtz, eds. Drug Fate and Metabolism. New York: Marcel Dekker, 1977, pp 187-228.
55. MC Meyer, DE Guttman. Dynamic dialysis as a method for studying protein binding. II: Evaluation of the method with a number of binding systems. J Pharm Sci 59: 39-48, 1970.
56. JM Weissbrod, RK Jain, FM Sirotnak. Pharmacokinetics of methotrexate in leukemia cells: Effect of dose and mode of injection. J Pharmacokin Biopharm 6:487-503, 1978.
57. FG King, RL Dedrick. Physiological model for the pharmacokinetics of 2'-deoxycoformycin in normal and leukemic mice. J Pharmacokin Biopharm 9:519-534, 1981.
58. JM Gallo, EE Hassan, DG Groothius. Targeting anticancer drugs to the brain. II. Physiological pharmacokinetic model of oxantrazole following intraarterial administration to rat glioma-2 (RG-2) bearing rats. J Pharmacokin Biopharm 21:575-592, 1993.
59. D Verotta, LB Sheiner, WF Ebling, DR Stanski. A semiparametric approach to physiological flow models. J Pharmacokin Biopharm 17:463-491, 1989.
60. FY Bois, TJ Woodruff, RC Spear. Comparison of three physiologically based pharmacokinetic models of benzene disposition. Toxicol Appl Pharmacol 110:79-88, 1991.
61. RS Thomas, WE Lytle, TJ Keefe, AA Constan, RSH Yang. Incorporating Monte Carlo simulation into physiologically based pharmacokinetic models using advanced continuous simulation language (ACSL): A computational method. Fundam Appl Toxicol 31:19-28, 1996.